We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Study Coupons' Impact on Perception of Rx Risks in DTC Ads
FDA to Study Coupons' Impact on Perception of Rx Risks in DTC Ads
February 10, 2006
The FDA plans to study how coupons and other price incentives affect consumer perceptions of drug risks and benefits in direct-to-consumer (DTC) print ads.